Ronald M. Avila-Sanchez

Gasteiz / Vitoria, PV 01007, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study.

Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study.

Journal: Ophthalmology and therapy

Published: May 10, 2025

Evaluation of Visual, Refractive, and Functional Outcomes after Implantation of an Extended Depth of Focus Intraocular Lens in Patients with Stable and Mild Glaucoma.

Evaluation of Visual, Refractive, and Functional Outcomes after Implantation of an Extended Depth of Focus Intraocular Lens in Patients with Stable and Mild Glaucoma.

Journal: Ophthalmology and therapy

Published: January 09, 2025

Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease.

Efficacy and Safety of Plasma Rich in Growth Factor in Patients with Congenital Aniridia and Dry Eye Disease.

Journal: Diseases (Basel, Switzerland)

Published: February 09, 2024

Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease.

Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: March 31, 2023

Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy.

Plasma Rich in Growth Factors as an Adjuvant Agent in Non-Penetrating Deep Sclerectomy.

Journal: Journal of clinical medicine

Published: March 05, 2023

Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.

Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.

Journal: Current eye research

Published: January 25, 2023

Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy in a referral center in Spain.

Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy in a referral center in Spain.

Journal: Archivos de la Sociedad Espanola de Oftalmologia

Published: January 28, 2022

Plasma Rich in Growth Factors in Macular Hole Surgery.

Plasma Rich in Growth Factors in Macular Hole Surgery.

Journal: Clinics and practice

Published: October 21, 2021

Membrane of Plasma Rich in Growth Factors in Primary Pterygium Surgery Compared to Amniotic Membrane Transplantation and Conjunctival Autograft.

Membrane of Plasma Rich in Growth Factors in Primary Pterygium Surgery Compared to Amniotic Membrane Transplantation and Conjunctival Autograft.

Journal: Journal of clinical medicine

Published: October 21, 2021

Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus.

Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus.

Journal: Expert opinion on biological therapy

Published: July 19, 2021

Differentiation of Features of Inflammatory Neovascular Membrane Versus Active Posterior Uveitis by SS-OCTA.

Differentiation of Features of Inflammatory Neovascular Membrane Versus Active Posterior Uveitis by SS-OCTA.

Journal: Ophthalmic surgery, lasers & imaging retina

Published: May 26, 2021

Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases.

Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases.

Journal: Vision (Basel, Switzerland)

Published: May 11, 2021

Showing 1-12 of 36

Last Updated: 09/26/2026